[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371361-105":59,"doc-detail-371361-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dual-mode-treatment-of-hepatocellular-carcinoma-using-rgd-cyclopeptide-modified-liposomes-loaded-with-ce6dox","Dual-Mode Treatment of Hepatocellular Carcinoma Using RGD Cyclopeptide-Modified Liposomes Loaded with Ce6/DOX","","Liver cancer treatment is constrained by limited systemic options and only modest survival gains, largely because drug effectiveness depends on achieving sufficient concentration at the tumor site. This study develops cRGD-modified, Ce6/DOX-loaded liposomes to enhance targeted accumulation and enable selective release with lysosomal escape. Using flow cytometry and ultrasound-stimulated experiments, it links sonodynamic reactive oxygen species generation to non-lysosomal drug release, and evaluates dual-modality therapeutic efficacy and biosafety in an HCC mouse tumor model.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dual-mode-treatment-of-hepatocellular-carcinoma-using-rgd-cyclopeptide-modified-liposomes-loaded-with-ce6dox/371361/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dual-mode-treatment-of-hepatocellular-carcinoma-using-rgd-cyclopeptide-modified-liposomes-loaded-with-ce6dox/371361.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study target in hepatocellular carcinoma therapy?","Question",{"text":112,"@type":113},"Systemic treatments offer limited survival benefits, and drug efficacy depends on achieving adequate concentration at the tumor site with selective release and lysosomal escape.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are the RGD cyclopeptide-modified liposomes prepared and functionalized?",{"text":117,"@type":113},"c(RGDyK) is modified onto the surface of drug-loaded liposomes containing Ce6 and doxorubicin via an amide reaction to provide targeting capability.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does ultrasound and sonodynamic therapy play in drug release?",{"text":121,"@type":113},"Ultrasound-driven sonodynamic therapy generates reactive oxygen species, which promote effective drug release from the carrier into the non-lysosomal region.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371361,1790639799,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","International Journal of Nanomedicine  \nOpen Access Full Text Article ORIGINAL RESEARCH  \nDual-Mode Treatment of Hepatocellular Carcinoma Using RGD Cyclopeptide-Modified Liposomes Loaded with Ce6/DOX  \nWentao Xu 1 , 2 , *, Jiajia Zheng 1 , 2 , *, Jiaqi Zhang 1 , *, Houhui Shi 3 , *, Weili Peng 1 , Yang Liu4 , Guodong Feng 5 , Yuguang Wang2 , Yi-Jun Liang 6 , Jun Chen 1  \n1Cancer Center, Department of Interventional Medicine, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, 310014, People’s Republic of China; 2College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, People’s Republic of China; 3College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, People’s Republic of China; 4Cancer Center, Department of Ultrasound Medicine, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, People’s Republic of China; 5Department of Radiology, Minhang Hospital, Fudan University, Shanghai, People’s Republic of China; 6School of Medicine & School of Mechatronic Engineering and Automation, Foshan University, Foshan, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Jun Chen; Yi-Jun Liang, Email [chenjun@hmc.edu.cn](chenjun@hmc.edu.cn); [liangyijun@fosu.edu.cn](liangyijun@fosu.edu.cn)  \n\n| Background: Liver cancer is one of the most prevalent cancers globally, with approximately 90% of primary liver cancers being hepatocellular carcinomas (HCC) . However, current systemic treatment options (whether monotherapy or combination therapy) are limited and offer only modest survival benefits. The effectiveness of a drug is largely determined by its concentration at the target site. Therefore, an effective drug delivery system must enhance drug accumulation at the target site, enable selective drug release there, and facilitate escape from lysosomes.\u003Cbr>Methods: cRGD-Lipo@Ce6/DOX was prepared by modifying c(RGDyK) onto the surface of drug-loaded liposomes containing Chlorin e6 (Ce6) and doxorubicin (DOX) through an amide reaction. The targeting capability and uptake mechanism of cRGD-Lipo @Ce6/DOX for HCC were analyzed using flow cytometry. To investigate drug release mechanisms and changes in subcellular distribution following ultrasound stimulation, further studies were conducted. The therapeutic efficacy and biosafety of this dualmodality therapy were then evaluated in an HCC subcutaneous tumor-bearing mouse model.\u003Cbr>Results: The prepared nanocomplex exhibits a surface charge of −9.91 ± 2.94 mV and an apparent size of 118.07 ± 1.46 nm. Modification of the RGD cyclic peptide on the surface of the drug-carrying liposomes enhanced the targeting and penetration efficiency for HCC. In vitro experiments on drug uptake mechanisms and release demonstrated that reactive oxygen species (ROS) generated by sonodynamic therapy (SDT) promote effective drug release from the carrier into the non-lysosomal region. The combined SDT and chemotherapy treatment achieved a 94% tumor inhibition rate and showed excellent biosafety in HCC subcutaneous tumor-bearing mice.\u003Cbr>Conclusion: Therefore, the effectiveness of the combination treatment strategy utilizing SDT in conjunction with chemotherapy provides additional treatment options for patients with HCC.\u003Cbr>Keywords: hepatocellular carcinomas, sonodynamic therapy, dual-modality therapy, lysosomal escape |\n| --- |\n| Introduction\u003Cbr>Hepatocellular carcinoma (HCC) represents 80% of all primary liver cancers worldwide and is the sixth most common cancer and the third leading cause of cancer-related deaths.1 Due to the typically late appearance of symptoms, more than half of HCC cases are diagnosed at an advanced stage, often necessitating systemic treatment.2,3 In the past, doxorubicin (DOX) was a primary first-line anticancer drug for various cancers, including advanced HCC. Howev","cbCaiux60eoZQBMY","https://ap.wps.com/l/cbCaiux60eoZQBMY","pdf",13742701,16,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What problem does the study target in hepatocellular carcinoma therapy?\",\"answer\":\"Systemic treatments offer limited survival benefits, and drug efficacy depends on achieving adequate concentration at the tumor site with selective release and lysosomal escape.\"},{\"question\":\"How are the RGD cyclopeptide-modified liposomes prepared and functionalized?\",\"answer\":\"c(RGDyK) is modified onto the surface of drug-loaded liposomes containing Ce6 and doxorubicin via an amide reaction to provide targeting capability.\"},{\"question\":\"What role does ultrasound and sonodynamic therapy play in drug release?\",\"answer\":\"Ultrasound-driven sonodynamic therapy generates reactive oxygen species, which promote effective drug release from the carrier into the non-lysosomal region.\"}]","Dual-Mode Treatment of Hepatocellular Carcinoma Using RGD Cyclopeptide-Modified Liposomes Loaded with Ce6/DOX | PDF",1790191893,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39bea63f7f6e1dff0f0662961aae2062.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbdf7fa7a103fa38eec79c22f332b967.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/619551ca750808c7571980707f7d4f09.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00c3eba8dd20da4bcc2cf1c37cd68e5d.webp",980,1268]